Nintedanib in Japanese patients with idiopathic pulmonary fibrosis: A subgroup analysis of the INPULSIS® randomized trials-Reference-Cited by-同舟云学术

Nintedanib in Japanese patients with idiopathic pulmonary fibrosis: A subgroup analysis of the INPULSIS® randomized trials

Published:2016-12-20 Issue:4 Volume:22 Page:750-757
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Azuma Arata¹,Taniguchi Hiroyuki²,Inoue Yoshikazu³,Kondoh Yasuhiro²,Ogura Takashi⁴,Homma Sakae⁵,Fujimoto Tsuyoshi⁶,Sakamoto Wataru⁶,Sugiyama Yukihiko⁷,Nukiwa Toshihiro⁸

Affiliation:

1. Department of Pulmonary Medicine and Oncology; Graduate School of Medicine, Nippon Medical School; Tokyo Japan

2. Department of Respiratory Medicine and Allergy; Tosei General Hospital; Aichi Japan

3. Clinical Research Center; National Hospital Organization Kinki-Chuo Chest Medical Center; Osaka Japan

4. Department of Respiratory Medicine; Kanagawa Cardiovascular and Respiratory Center; Kanagawa Japan

5. Department of Respiratory Medicine; Toho University Omori Medical Center; Tokyo Japan

6. Nippon Boehringer Ingelheim Co. Ltd.; Tokyo Japan

7. Division of Pulmonary Medicine, Department of Medicine; Jichi Medical University; Tochigi Japan

8. Research Institute of Tuberculosis; Japan Anti-tuberculosis Association; Tokyo Japan

Funder

Ministry of Health, Labour and Welfare of Japan

Boehringer Ingelheim

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.12960/fullpdf

Reference21 articles.

1. Raghu G Collard HR Egan JJ Martinez FJ Behr J Brown KK Colby TV Cordier JF Flaherty KR Lasky JA et al ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med 2011 183:

2. Idiopathic pulmonary fibrosis;Meltzer;Orphanet J. Rare Dis.,2008

3. Clinical course and prediction of survival in idiopathic pulmonary fibrosis;Ley;Am. J. Respir. Crit. Care Med.,2011

4. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences;Natsuizaka;Am. J. Respir. Crit. Care Med.,2014

5. Classification and natural history of the idiopathic interstitial pneumonias;Kim;Proc. Am. Thorac. Soc.,2006

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-UBE2T antibody: A novel biomarker of progressive-fibrosing interstitial lung disease;Respiratory Investigation;2023-09

2. Nintedanib administration after the onset of acute exacerbation of interstitial lung disease in the real world;Scientific Reports;2023-08-02

3. Expectations, symptoms, and quality of life before and after 1 year of Pirfenidone treatment in patients with idiopathic pulmonary fibrosis: A single‐arm, open‐label nonrandomized study;Health Science Reports;2023-08

4. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans;Drug Metabolism and Disposition;2023-03-16

5. Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan;Advances in Therapy;2023-01-24